NCT00282516 2025-02-10
Asthma In-Home Monitoring (AIM) Trial
Tripler Army Medical Center
Phase NA Completed
Clinical Trials
24 trialsNCT06061172 2024-12-12
gp-multitool
Universitätsklinikum Hamburg-Eppendorf
Phase NA Completed
NCT06457269 2024-11-27
EPLLMMRDC
North Sichuan Medical College
Phase NA Completed
NCT04574050 2024-03-19
SELF-BREATHE RCT for Chronic Breathlessness
King's College Hospital NHS Trust
Phase NA Completed
NCT02232126 2023-11-09
SWIFT
University of Southern California
Phase NA Completed
NCT03916237 2023-10-19
CREST
MetroHealth Medical Center
Phase NA Completed
NCT02742597 2023-03-17
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT02517099 2023-03-06
PrIGMa
Imperial College London
Phase 2 Completed
NCT02789800 2022-11-03
PACEinMM-QC
Université de Sherbrooke
Phase NA Completed
NCT02808689 2021-04-01
FAst
The Cleveland Clinic
Phase NA Completed
NCT02773095 2020-04-29
Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative
Boston University
Phase NA Completed
NCT03369847 2019-07-18
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
New York City Health and Hospitals Corporation
Phase 4 Completed
NCT02022761 2018-05-30
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Vaxart
Phase 1 Completed
NCT00455923 2018-02-05
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
GlaxoSmithKline
Phase 4 Completed
NCT02440906 2017-10-03
WIN
University of Florida
Phase NA Completed
NCT00001893 2017-07-02
Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02105012 2017-06-06
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Pearl Therapeutics, Inc.
Phase 2 Completed
NCT00461500 2017-03-03
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
GlaxoSmithKline
Phase 4 Completed
NCT01089322 2017-02-16
Risk Factors Associated to Difficult-to-control Asthma
University of Sao Paulo General Hospital
Phase 4 Completed
NCT00621946 2014-02-04
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
University of Texas Southwestern Medical Center
Phase 4 Completed
NCT00646516 2011-01-24
Gemini Symbicort pMDI
AstraZeneca
Phase 3 Completed
NCT00141791 2009-08-07
Study Evaluating Etanercept in Moderate to Severe Asthma
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 2 Completed
NCT00850265 2009-03-27
Effect of Spacer in Extrafine Formoterol-Beclomethasone Treatment to Asthma
Hospital General de Requena
Phase NA Completed
NCT00276029 2006-05-04
TNF Alpha in Refractory Asthma
University Hospitals, Leicester
Phase NA Completed